Reply to v.R. Bhatt et Al and m.C. Chamberlain

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Brain Neoplasms / secondary*
• Brain Neoplasms / therapy*
• Carcinoma, Non-Small-Cell Lung / secondary*
• Carcinoma, Non-Small-Cell Lung / therapy*
• Cranial Irradiation*
• ErbB Receptors / antagonists & inhibitors*
• ErbB Receptors / genetics*
• Female
• Humans
• Lung Neoplasms / pathology*
• Male
• Mutation*
• Quinazolines / therapeutic use*